Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "Asia"

643 News Found

DKSH acquires two ear care brands
News | October 14, 2022

DKSH acquires two ear care brands

DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.


Cipla’s Indore plant joins the WEF's Lighthouse Network
Digitisation | October 12, 2022

Cipla’s Indore plant joins the WEF's Lighthouse Network

Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations


Sitaram Jaipuria Foundation felicitates doctors at the Medical & Healthcare Excellence Awards 2022
News | October 11, 2022

Sitaram Jaipuria Foundation felicitates doctors at the Medical & Healthcare Excellence Awards 2022

Monetary awards worth Rs 1.20 crore were presented amongst the winners for their remarkable contributions


Thermo Fisher Scientific emphasizes on the need for more disruptive technologies
Medical Device | October 09, 2022

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.


Pfizer acquires Global Blood Therapeutics
News | October 09, 2022

Pfizer acquires Global Blood Therapeutics

Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community


Matt Sause elevated as new CEO of Roche Diagnostics
People | October 04, 2022

Matt Sause elevated as new CEO of Roche Diagnostics

Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.


Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData
News | October 01, 2022

Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData

The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.


Lupin receives US FDA approval for Mirabegron Extended-Release tablets
Drug Approval | September 30, 2022

Lupin receives US FDA approval for Mirabegron Extended-Release tablets

Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US


Emmes acquires Clinical Edge
News | September 30, 2022

Emmes acquires Clinical Edge

The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services